JBIO vs DSGN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

JBIO

52.1
AI Score
VS
JBIO Wins

DSGN

51.7
AI Score

Investment Advisor Scores

JBIO

52score
Recommendation
HOLD

DSGN

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JBIO DSGN Winner
Net Income -40.37M -8.28M DSGN
Operating Income -43.45M -8.33M DSGN
ROE -13.6% 73.2% DSGN
ROA -12.6% -22.7% JBIO
Total Assets 319.43M 36.52M JBIO
Cash 55.09M 2.38M JBIO
Current Ratio 14.29 15.55 DSGN
Free Cash Flow -24.28M -8.74M DSGN

Relative Price Performance (Last 90 Days)

JBIO 1M: -11.0% · 3M: -21.0% DSGN 1M: -18.4% · 3M: -4.1%

Current Technical Phase

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.3%), weak momentum, RSI 42

RSI (14): 42.1 · Price: $19.15

DSGN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $12.76

Fundamentals Snapshot

Metric JBIO DSGN
Market Cap
Forward P/E -8.7 -7.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin -1761.5%
Operating Margin 0.0% 0.0%
EPS -2.72 -1.20
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.